Sarah Duncan MRCP, Dip HIV, Lucy Dorrell DM, FRCP Nuffield
{"title":"有希望的艾滋病治疗新药和药物靶点","authors":"Sarah Duncan MRCP, Dip HIV, Lucy Dorrell DM, FRCP Nuffield","doi":"10.1002/fps.108","DOIUrl":null,"url":null,"abstract":"<p>The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long-term control of HIV are side-effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"14 2","pages":"13-16"},"PeriodicalIF":0.0000,"publicationDate":"2013-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.108","citationCount":"1","resultStr":"{\"title\":\"Promising new drugs and drug targets for HIV treatment\",\"authors\":\"Sarah Duncan MRCP, Dip HIV, Lucy Dorrell DM, FRCP Nuffield\",\"doi\":\"10.1002/fps.108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long-term control of HIV are side-effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.</p>\",\"PeriodicalId\":100566,\"journal\":{\"name\":\"Future Prescriber\",\"volume\":\"14 2\",\"pages\":\"13-16\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-12-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/fps.108\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fps.108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Promising new drugs and drug targets for HIV treatment
The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long-term control of HIV are side-effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
